G-BA brings clarity to registry requirements
Using the gene therapy Zolgensma as its first case, the Gemeinsame Bundesausschuss (G-BA, Federal Joint Committee) has set its rules … read more »
Medicines Discovery Catapult announced 22 partnerships with UK-based CROs
The UK government hopes that research and development will be boosted thanks to the Medicines Discovery Catapult, which aims to … read more »
Parliamentary Exchange on the NHS and Drugs – Answered 21st March 2017
Rt Hon Stephen Timms MP for East Ham asked the Secretary of State for Health, pursuant to the Answer of 23 … read more »
Office of Health Economics Variations in Access to Orphan Drugs Across Europe
The Office of Health Economics have published a report which compares the availability of and access to orphan medicinal products (OMPs) in the UK (England, … read more »
House of Commons Exchange on Innovative Drugs and Medical Devices
Please see below the following exchange on Innovative Drugs and Medical Devices from the House of commons on the 7th February … read more »
